References
- Amundadottir L, Kraft P, Stolzenberg-Solomon RZ (2009). Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet, 41, 986-90. https://doi.org/10.1038/ng.429
- Arslan AA, Helzlsouer KJ, Kooperberg C. Anthropometric measures, body mass index, and pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 170, 791-802.
- Capelle C, Solcia E, Kloppel G, Hruban RH (2000). Serous cystic neoplasms of the pancreas. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. IARC Press Lyon.
- Carey AH, Waterworth D, Patel K, et al. (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet , 3, 1873-6. https://doi.org/10.1093/hmg/3.10.1873
- Duell EJ, Elizabeth AHolly, Karl TKelsey and Paige MBracc (2010). Genetic variation in CYP17 A1and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area. Int J Cancer, 126 , 790-5 https://doi.org/10.1002/ijc.24792
- Duell EJ, Holly EA (2005). Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol, 161,741-7. https://doi.org/10.1093/aje/kwi104
- Feigelson HS, Shames LS, Pike MC, et al (1998). BE.Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res, 58, 585-7.
- Feigelson, HS, Coetzee, GA, Kolonel, LN, Ross, R.K and Henderson, B.E, (1997). A Polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res, 57, 1063–5.
- Fernandez-del CC, Jimenez RE, Steer M (2005) Surgery in the treatment of pancreatic cancer. Up To Date.
- Hruban RH, Canto MI, Goggins M, Schulick R, Klein AP. Update on familial pancreatic cancer. Adv Surg, 44, 293-311.
- Iodice S, Gandini S, Maisonneuve P, Lowenfels A.B (2008). Tobacco and the risk of pancreatic cancer: A review and meta-analysis. Langenbecks Arch Surg, 393, 535-45. https://doi.org/10.1007/s00423-007-0266-2
- Jones S, Hruban RH, Kamiyama M, (2009). Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science, 324, 217. https://doi.org/10.1126/science.1171202
- Kemery G (2006). Pancreatic cancer. Epidemiology and pathology. Pract Gastroenterol, 30, 22-32.
- Kloppel G, Hruban RH, Longnecker DS, Adler G Ductal (2000). Adenocarcinoma of the pancreas. World Health Organization classification of tumours: pathology and genetics of tumours of the digestive system. IARC Press X.
- Laethem V and Marechal R (2007). Emerging drugs for the treatment of pancreatic cancer. Expert Opin Emerg Drugs, 12, 301-11. https://doi.org/10.1517/14728214.12.2.301
- Lucenteforte E, La Vecchia C, Silverman D (2011). Alcohol consumption and pancreatic cancer: A pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol, 22,1420-6. https://doi.org/10.1093/annonc/mdq613
- Lynch HT, Brand RE, Hogg D. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: The familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer, 94, 84-96.
- Lynch HT, Smyrk T, Kern SE (1996). Familial pancreatic cancer: A review. Semin Oncol, 23, 251-75.
- Murphy KM, Brune KA, Griffin C (2002). Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: Deleterious BRCA2 mutations in 17%. Cancer Res, 62, 3789-93.
- Nedelcheva KV, Haraldsen EK, AndersonKB, et al(1994). CYP17and breast cancer risk: the polymorphism in the 50 flanking area of the gene does not influence binding to Sp-1. Cancer Res, 59, 2825-8.
- Olson SH, Bandera EV, Orlow I (2007). Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol, 165, 235-45. https://doi.org/10.1093/aje/kwk015
- Setiawan VW, Schumacher FR, Haiman CA, et al(2007). CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev, 16, 2237-46. https://doi.org/10.1158/1055-9965.EPI-07-0589
- Sharp L, Cardy A.H, Cotton S.C, Little J. (2006) CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors: a HuGE review. Am J Epidemiol, 160, 729-40.
- Steer M (2005). Clinical manifestation, diagnosis and surgical staging of exocrine pancreatic cancer. Up To Date. Br J Cancer, 93, 740. https://doi.org/10.1038/sj.bjc.6602760
- Su GH, Hruban RH, Bansal RK, (1999). Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol, 154, 1835-40. https://doi.org/10.1016/S0002-9440(10)65440-5
- Tworoger SS, Chubak J, Aiello EJ, et al. Association of CYP17. CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 13, 94-101.
- Victor K, Chen MD, Miguel R, Arguedas MD (2004). A cost minimization analysis of alternative strategies in diagnosing pancreatic cancer. Am J Gastroenterol, 99, 2223-34. https://doi.org/10.1111/j.1572-0241.2004.40042.x